Microbot Non Current Assets Total vs Short Term Investments Analysis

MBOT Stock

USD 0.88 0.05 5.38%

Microbot Medical financial indicator trend analysis is infinitely more than just investigating Microbot Medical recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Microbot Medical is a good investment. Please check the relationship between Microbot Medical Non Current Assets Total and its Short Term Investments accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Microbot Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

For more information on how to buy Microbot Stock please use our How to Invest in Microbot Medical guide.

Non Current Assets Total vs Short Term Investments

Non Current Assets Total vs Short Term Investments Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Microbot Medical Non Current Assets Total account and Short Term Investments. At this time, the significance of the direction appears to have weak contrarian relationship.

The correlation between Microbot Medical's Non Current Assets Total and Short Term Investments is -0.03. Overlapping area represents the amount of variation of Non Current Assets Total that can explain the historical movement of Short Term Investments in the same time period over historical financial statements of Microbot Medical, assuming nothing else is changed. The correlation between historical values of Microbot Medical's Non Current Assets Total and Short Term Investments is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Non Current Assets Total of Microbot Medical are associated (or correlated) with its Short Term Investments. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Short Term Investments has no effect on the direction of Non Current Assets Total i.e., Microbot Medical's Non Current Assets Total and Short Term Investments go up and down completely randomly.

Correlation Coefficient

-0.03

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Non Current Assets Total

The total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets.

Short Term Investments

Short Term Investments is an item under the current assets section of Microbot Medical balance sheet. It contains any investments Microbot Medical undertook that will expire in less than one year. These accounts contain financial instruments such as stocks or bonds that Microbot Medical can easily liquidate in the marketplace.

Most indicators from Microbot Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Microbot Medical current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Microbot Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

For more information on how to buy Microbot Stock please use our How to Invest in Microbot Medical guide.At this time, Microbot Medical's Sales General And Administrative To Revenue is comparatively stable compared to the past year. Enterprise Value is likely to gain to about 28.5 M in 2024, whereas Selling General Administrative is likely to drop 3,924 in 2024.

Microbot Medical fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Property Plant And Equipment Gross	Common Stock Total Equity	Common Stock	Short Term Investments	Current Deferred Revenue
Total Assets		0.56	0.32	0.58	0.63	0.67	-0.73	-0.6	0.01	0.9	0.73	0.53	0.97	-0.1	-0.43	0.7	0.54	0.64	0.69	0.97	0.57	0.34	0.36	0.34	0.01	-0.21
Short Long Term Debt Total	0.56		0.71	0.86	-0.17	0.94	-0.07	-0.75	-0.04	0.6	0.68	0.09	0.45	-0.01	-0.46	0.83	0.07	0.75	0.87	0.46	0.96	0.51	0.46	0.45	-0.4	-0.27
Other Current Liab	0.32	0.71		0.9	-0.48	0.75	0.33	-0.88	0.36	0.12	0.72	0.41	0.12	0.13	-0.42	0.8	-0.08	0.87	0.86	0.15	0.61	0.32	0.64	0.65	-0.21	-0.43
Total Current Liabilities	0.58	0.86	0.9		-0.2	0.87	0.0	-0.87	0.28	0.47	0.75	0.4	0.42	0.16	-0.38	0.84	0.21	0.86	0.93	0.45	0.8	0.38	0.56	0.56	-0.31	-0.42
Total Stockholder Equity	0.63	-0.17	-0.48	-0.2		-0.06	-0.92	0.19	-0.18	0.66	0.03	0.23	0.77	-0.16	0.04	-0.09	0.63	-0.14	-0.12	0.76	-0.1	0.01	-0.22	-0.24	0.25	0.15
Property Plant And Equipment Net	0.67	0.94	0.75	0.87	-0.06		-0.14	-0.85	0.13	0.63	0.82	0.33	0.54	-0.05	-0.55	0.89	0.1	0.86	0.92	0.54	0.86	0.63	0.62	0.61	-0.23	-0.22
Net Debt	-0.73	-0.07	0.33	0.0	-0.92	-0.14		-0.06	0.02	-0.84	-0.19	-0.33	-0.83	0.24	0.18	-0.09	-0.66	0.02	-0.07	-0.82	-0.12	-0.13	0.02	0.05	-0.04	-0.16
Retained Earnings	-0.6	-0.75	-0.88	-0.87	0.19	-0.85	-0.06		-0.25	-0.36	-0.91	-0.55	-0.42	-0.03	0.54	-0.95	0.01	-1.0	-0.96	-0.43	-0.68	-0.36	-0.76	-0.76	0.14	0.49
Accounts Payable	0.01	-0.04	0.36	0.28	-0.18	0.13	0.02	-0.25		-0.04	0.34	0.65	-0.1	0.11	-0.19	0.13	-0.08	0.24	0.19	-0.09	-0.07	0.2	0.56	0.58	0.05	0.05
Cash	0.9	0.6	0.12	0.47	0.66	0.63	-0.84	-0.36	-0.04		0.52	0.32	0.92	-0.19	-0.39	0.53	0.57	0.4	0.53	0.92	0.61	0.39	0.24	0.2	-0.18	-0.02
Non Current Assets Total	0.73	0.68	0.72	0.75	0.03	0.82	-0.19	-0.91	0.34	0.52		0.66	0.57	-0.03	-0.64	0.94	0.04	0.92	0.91	0.56	0.64	0.47	0.76	0.75	-0.03	-0.3
Non Currrent Assets Other	0.53	0.09	0.41	0.4	0.23	0.33	-0.33	-0.55	0.65	0.32	0.66		0.41	-0.23	-0.55	0.47	0.37	0.56	0.47	0.43	0.04	0.2	0.75	0.74	0.13	-0.11
Cash And Short Term Investments	0.97	0.45	0.12	0.42	0.77	0.54	-0.83	-0.42	-0.1	0.92	0.57	0.41		-0.13	-0.32	0.55	0.58	0.47	0.53	0.99	0.5	0.27	0.18	0.15	0.04	-0.14
Net Receivables	-0.1	-0.01	0.13	0.16	-0.16	-0.05	0.24	-0.03	0.11	-0.19	-0.03	-0.23	-0.13		0.61	-0.02	-0.2	0.02	0.02	-0.11	0.08	-0.07	-0.22	-0.16	0.02	-0.21
Common Stock Shares Outstanding	-0.43	-0.46	-0.42	-0.38	0.04	-0.55	0.18	0.54	-0.19	-0.39	-0.64	-0.55	-0.32	0.61		-0.64	-0.09	-0.54	-0.59	-0.3	-0.41	-0.51	-0.66	-0.6	-0.07	-0.2
Non Current Liabilities Total	0.7	0.83	0.8	0.84	-0.09	0.89	-0.09	-0.95	0.13	0.53	0.94	0.47	0.55	-0.02	-0.64		0.04	0.96	0.98	0.54	0.8	0.43	0.69	0.67	-0.16	-0.39
Other Current Assets	0.54	0.07	-0.08	0.21	0.63	0.1	-0.66	0.01	-0.08	0.57	0.04	0.37	0.58	-0.2	-0.09	0.04		0.02	0.11	0.64	0.07	-0.04	-0.05	-0.08	-0.14	-0.01
Other Stockholder Equity	0.64	0.75	0.87	0.86	-0.14	0.86	0.02	-1.0	0.24	0.4	0.92	0.56	0.47	0.02	-0.54	0.96	0.02		0.96	0.48	0.68	0.36	0.76	0.76	-0.13	-0.48
Total Liab	0.69	0.87	0.86	0.93	-0.12	0.92	-0.07	-0.96	0.19	0.53	0.91	0.47	0.53	0.02	-0.59	0.98	0.11	0.96		0.54	0.83	0.43	0.67	0.66	-0.22	-0.41
Total Current Assets	0.97	0.46	0.15	0.45	0.76	0.54	-0.82	-0.43	-0.09	0.92	0.56	0.43	0.99	-0.11	-0.3	0.54	0.64	0.48	0.54		0.48	0.26	0.19	0.16	0.02	-0.15
Short Term Debt	0.57	0.96	0.61	0.8	-0.1	0.86	-0.12	-0.68	-0.07	0.61	0.64	0.04	0.5	0.08	-0.41	0.8	0.07	0.68	0.83	0.48		0.48	0.36	0.34	-0.34	-0.24
Property Plant And Equipment Gross	0.34	0.51	0.32	0.38	0.01	0.63	-0.13	-0.36	0.2	0.39	0.47	0.2	0.27	-0.07	-0.51	0.43	-0.04	0.36	0.43	0.26	0.48		0.31	0.29	0.38	0.58
Common Stock Total Equity	0.36	0.46	0.64	0.56	-0.22	0.62	0.02	-0.76	0.56	0.24	0.76	0.75	0.18	-0.22	-0.66	0.69	-0.05	0.76	0.67	0.19	0.36	0.31		1.0	-0.23	-0.25
Common Stock	0.34	0.45	0.65	0.56	-0.24	0.61	0.05	-0.76	0.58	0.2	0.75	0.74	0.15	-0.16	-0.6	0.67	-0.08	0.76	0.66	0.16	0.34	0.29	1.0		-0.24	-0.29
Short Term Investments	0.01	-0.4	-0.21	-0.31	0.25	-0.23	-0.04	0.14	0.05	-0.18	-0.03	0.13	0.04	0.02	-0.07	-0.16	-0.14	-0.13	-0.22	0.02	-0.34	0.38	-0.23	-0.24		0.58
Current Deferred Revenue	-0.21	-0.27	-0.43	-0.42	0.15	-0.22	-0.16	0.49	0.05	-0.02	-0.3	-0.11	-0.14	-0.21	-0.2	-0.39	-0.01	-0.48	-0.41	-0.15	-0.24	0.58	-0.25	-0.29	0.58

Click cells to compare fundamentals

Microbot Medical Account Relationship Matchups

Microbot Medical fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	37.1M	26.3M	16.8M	9.5M	8.3M	7.9M
Other Current Liab	608K	(131K)	396K	1.7M	3.2M	2.6M
Total Current Liabilities	4.8M	1.3M	2.0M	2.1M	3.8M	4.8M
Total Stockholder Equity	31.5M	24.3M	14.4M	7.3M	4.5M	4.3M
Property Plant And Equipment Net	1.2M	1.0M	888K	723K	406K	385.7K
Net Debt	(27.9M)	(18.8M)	(12.8M)	(2.0M)	(2.3M)	(2.4M)
Retained Earnings	(35.1M)	(44.3M)	(55.6M)	(68.8M)	(79.5M)	(83.5M)
Accounts Payable	284K	275K	279K	116K	357K	489.2K
Cash	28.8M	19.7M	13.5M	2.4M	2.5M	2.4M
Non Current Assets Total	1.2M	1.0M	888K	723K	406.0K	385.7K
Non Currrent Assets Other	259K	962K	5.0K	(1.0)	(0.9)	(0.85)
Cash And Short Term Investments	31.3M	24.6M	15.5M	8.2M	6.4M	6.1M
Net Receivables	101K	340K	174K	103K	1.3M	1.4M
Common Stock Shares Outstanding	4.3M	7.1M	7.1M	7.3M	10.2M	10.7M
Liabilities And Stockholders Equity	37.1M	26.3M	16.8M	9.5M	8.3M	7.9M
Non Current Liabilities Total	760K	626K	402K	179K	40K	38K
Other Current Assets	7.2M	270K	387K	612K	152K	144.4K
Other Stockholder Equity	66.6M	68.5M	69.9M	76.0M	83.9M	88.1M
Total Liab	5.6M	2.0M	2.4M	2.2M	3.8M	3.6M
Total Current Assets	35.9M	25.3M	15.9M	8.8M	7.9M	7.5M
Property Plant And Equipment Gross	1.2M	251.0	1.2M	1.1M	899K	854.1K
Common Stock Total Equity	406K	31K	72K	72.0	64.8	61.56
Common Stock	406K	31K	72K	80K	118K	112.1K
Net Tangible Assets	31.5M	24.3M	14.4M	7.3M	8.4M	11.1M
Retained Earnings Total Equity	(20.6M)	(27.9M)	(35.1M)	(44.3M)	(50.9M)	(53.5M)
Capital Surpluse	30.2M	32.5M	70.0M	68.5M	61.7M	58.6M
Property Plant Equipment	228K	1.0M	888K	723K	650.7K	1.2M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Microbot Stock Analysis

When running Microbot Medical's price analysis, check to measure Microbot Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Microbot Medical is operating at the current time. Most of Microbot Medical's value examination focuses on studying past and present price action to predict the probability of Microbot Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Microbot Medical's price. Additionally, you may evaluate how the addition of Microbot Medical to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC